Skip to content, Open navigation or Skip to contact information.

Copyright © Inderes 2011 - present. All rights reserved.
Latest
Markets
Stock Comparison
Calendar
Research
Articles
Insider transactions
inderesTV
Portfolio
Forum
About us
Our coverage
Team
Settings
Copyright © Inderes 2011 - present. All rights reserved.

Latest content

Showing All content types
Nightingale Health H2 on Thursday: Eyes kept on the horizon
Analyst Comment 22.09.2023 by Antti Luiro
Nightingale Health
Nightingale’s updated strategy focuses on corporate customers and the public sector
Analyst Comment 11.09.2023 by Antti Luiro
Nightingale Health
Nightingale’s blood analysis introduced in Terveystalo's occupational health services
Analyst Comment 31.08.2023 by Antti Luiro
Nightingale HealthTerveystalo
Aiforia: The journey won't be a straight line
Research 28.08.2023 by Antti Luiro, Frans-Mikael Rostedt
Aiforia Technologies
Nightingale Health deepens its strategic cooperation with Terveystalo
Analyst Comment 02.07.2023 by Antti Luiro
Nightingale Health
Nightingale Health: Seeking a commercial recipe for success
Extensive research 05.06.2023 by Antti Luiro
Nightingale Health
The importance of management
Article 24.04.2023 by Antti Luiro
Faron Pharmaceuticals: BEXMAB study’s good momentum supports valuation
Research 17.04.2023 by Antti Siltanen, Antti Luiro
Faron Pharmaceuticals
Nightingale Health: Giving commercialization time to take shape
Research 24.03.2023 by Antti Luiro
Nightingale Health
Nightingale Health H1 morning result: Growth was needed, growth was delivered
Analyst Comment 23.03.2023 by Antti Luiro
Nightingale Health